Clinical Trial Update: Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome

View source ↗

Summary

A clinical trial evaluating anti-JAK1 inhibitors in patients with Aicardi-Goutières Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aicardi-goutières Syndrome

Drugs mentioned

• JAK1 inhibitors (anti-JAK1) (JAK1 inhibitor)

Snippet

Sponsor: IRCCS Fondazione Stella Maris | Conditions: Aicardi-Goutières Syndrome (AGS) | Status: COMPLETED